Aveo Pharmaceuticals Inc
NASDAQ:AVEO
Aveo Pharmaceuticals Inc
Common Shares Outstanding
Aveo Pharmaceuticals Inc
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aveo Pharmaceuticals Inc
NASDAQ:AVEO
|
Common Shares Outstanding
$34.6m
|
CAGR 3-Years
29%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Common Shares Outstanding
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Shares Outstanding
$1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Shares Outstanding
$536.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Shares Outstanding
$258.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Shares Outstanding
$110.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Aveo Pharmaceuticals Inc's Common Shares Outstanding?
Common Shares Outstanding
34.6m
USD
Based on the financial report for Sep 30, 2022, Aveo Pharmaceuticals Inc's Common Shares Outstanding amounts to 34.6m USD.
What is Aveo Pharmaceuticals Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
24%
Over the last year, the Common Shares Outstanding growth was 1%. The average annual Common Shares Outstanding growth rates for Aveo Pharmaceuticals Inc have been 29% over the past three years , 24% over the past five years .